WO2026139053 - GLP-1 COMPOUND-CONTAINING PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/139053
Publication Date
02.07.2026
International Application No.
PCT/CN2025/146114
International Filing Date
26.12.2025
Title **
[English]
GLP-1 COMPOUND-CONTAINING PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF
[French]
COMPOSITION PHARMACEUTIQUE CONTENANT UN COMPOSÉ GLP-1, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
一种包含GLP-1化合物的药物组合物及其制备方法与应用
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
XU, Wenjie
ZHANG, Shu
JIANG, Jinjin
YE, Guanhao
HUA, Huaijie
LIAN, Xiaolei
Priority Data
202411984369.0
27.12.2024
CN
202510519103.7
23.04.2025
CN
202511429522.8
26.09.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2019 | |
| EPO | Filing, Examination, Granting | 14186 | |
| Japan | Filing, Examination, Granting | 2372 | |
| South Korea | Filing, Examination, Granting | 2616 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
25,933
Contact Us
Abstract[English]
Provided are a pharmaceutical composition and a use thereof for treating diseases. The pharmaceutical composition contains a GLP-1 compound and an absorption enhancer.[French]
L'invention concerne une composition pharmaceutique et son utilisation pour le traitement de maladies. La composition pharmaceutique contient un composé GLP-1 et un activateur d'absorption.[Chinese]
提供一种药物组合物，以及使用其治疗疾病的用途。该药物组合物包含一种GLP-1化合物和吸收促进剂。